| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Gulam H Syed | Q56435209 |
| Aleem Siddiqui | Q89717852 | ||
| P2093 | author name string | Yutaka Amako | |
| P2860 | cites work | Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells | Q24300446 |
| Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion | Q24337547 | ||
| Robust hepatitis C virus infection in vitro | Q27470013 | ||
| Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles | Q27472884 | ||
| Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection | Q27473003 | ||
| Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients | Q27473044 | ||
| Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles | Q27477620 | ||
| Critical role of PA28 in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis | Q27477993 | ||
| Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins | Q27478188 | ||
| Hepatitis C Virus Induces Proteolytic Cleavage of Sterol Regulatory Element Binding Proteins and Stimulates Their Phosphorylation via Oxidative Stress | Q27481013 | ||
| Studying Hepatitis C Virus: Making the Best of a Bad Virus | Q27481034 | ||
| Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins | Q27481398 | ||
| Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture | Q27485012 | ||
| Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion | Q27485447 | ||
| Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor | Q27485871 | ||
| Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection | Q27486112 | ||
| Characterization of hepatitis C RNA-containing particles from human liver by density and size | Q27486986 | ||
| Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response | Q27487012 | ||
| Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production | Q27487550 | ||
| Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins | Q27487558 | ||
| Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection | Q27487947 | ||
| Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication | Q27488365 | ||
| Role of Oxysterol Binding Protein in Hepatitis C Virus infection | Q27489539 | ||
| The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly | Q40066670 | ||
| Activation of the ER stress gene gadd153 by hepatitis C virus sensitizes cells to oxidant injury | Q40157434 | ||
| Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core | Q40190516 | ||
| The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. | Q40316761 | ||
| Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver | Q40392671 | ||
| Structure and function of the hepatitis C virus internal ribosome entry site | Q40411958 | ||
| Hepatitis C virus, ER stress, and oxidative stress | Q40432170 | ||
| An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation | Q40436187 | ||
| Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. | Q40463023 | ||
| UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. | Q42041480 | ||
| Anti-HCV activities of selective polyunsaturated fatty acids | Q42984636 | ||
| Hepatitis C virus and liver steatosis: when fat is not beautiful | Q42984820 | ||
| Serum lipid pattern in chronic hepatitis C: histological and virological correlations | Q42997238 | ||
| Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection | Q42997461 | ||
| Structural determinants that target the hepatitis C virus core protein to lipid droplets. | Q43000172 | ||
| Modification of host lipid raft proteome upon hepatitis C virus replication | Q43030998 | ||
| The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. | Q43034249 | ||
| Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis | Q43048093 | ||
| Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis | Q45733913 | ||
| VLDL exits from the endoplasmic reticulum in a specialized vesicle, the VLDL transport vesicle, in rat primary hepatocytes | Q46657622 | ||
| Very low density lipoprotein and low density lipoprotein isolated from patients with hepatitis C infection induce altered cellular lipid metabolism | Q61890245 | ||
| Apolipoprotein-AII concentrations are associated with liver steatosis in patients with chronic hepatitis C | Q80162458 | ||
| Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis | Q83334976 | ||
| A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus Replication | Q27489843 | ||
| Human occludin is a hepatitis C virus entry factor required for infection of mouse cells | Q27490169 | ||
| Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor | Q27490234 | ||
| Global epidemiology of hepatitis C virus infection | Q27860799 | ||
| Production of infectious hepatitis C virus in tissue culture from a cloned viral genome | Q27860899 | ||
| Complete replication of hepatitis C virus in cell culture | Q27860934 | ||
| The lipid droplet is an important organelle for hepatitis C virus production | Q28131709 | ||
| Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry | Q28131832 | ||
| Mechanism of action of fibrates on lipid and lipoprotein metabolism | Q28288187 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Mobilisation of triacylglycerol stores | Q28609406 | ||
| Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly | Q28624200 | ||
| SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver | Q29547646 | ||
| Genetic diversity and evolution of hepatitis C virus--15 years on | Q29547888 | ||
| Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids | Q29620653 | ||
| Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data | Q33404846 | ||
| Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication | Q33420226 | ||
| Synthesis and function of hepatic very-low-density lipoprotein | Q33975367 | ||
| Interaction of hepatitis C virus proteins with host cell membranes and lipids | Q34160337 | ||
| Different anti-HCV profiles of statins and their potential for combination therapy with interferon | Q34541863 | ||
| Targeting lipid metabolism in the treatment of hepatitis C virus infection | Q34745648 | ||
| Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin | Q34768265 | ||
| Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule- and dynein-dependent manner. | Q34779622 | ||
| SREBPs: transcriptional mediators of lipid homeostasis | Q35176927 | ||
| Hepatitis C virus particles and lipoprotein metabolism. | Q36054706 | ||
| Evolution and mechanism of apolipoprotein B-containing lipoprotein assembly | Q36125680 | ||
| PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice | Q36330881 | ||
| From structure to function: new insights into hepatitis C virus RNA replication | Q36366142 | ||
| Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment | Q36548487 | ||
| Hepatitis C virus entry | Q36946317 | ||
| Early steps of the hepatitis C virus life cycle | Q37032802 | ||
| Hepatitis C virus cell entry: role of lipoproteins and cellular receptors | Q37407538 | ||
| Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis | Q39969739 | ||
| Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice | Q39975807 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| virology | Q7215 | ||
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 33-40 | |
| P577 | publication date | 2009-10-23 | |
| P1433 | published in | Trends in Endocrinology and Metabolism | Q15265727 |
| P1476 | title | Hepatitis C virus hijacks host lipid metabolism | |
| P478 | volume | 21 |
| Q40056735 | A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients |
| Q97643148 | A global lipid map defines a network essential for Zika virus replication |
| Q59352094 | ABPP and Host-Virus Interactions |
| Q27468846 | ADP-ribosylation Factor-related Protein 1 Interacts with NS5A and Regulates Hepatitis C Virus Propagation |
| Q57782075 | Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma |
| Q38840313 | Activity-based profiling of the proteasome pathway during hepatitis C virus infection |
| Q39425985 | Adaptation of retrovirus producer cells to serum deprivation: Implications in lipid biosynthesis and vector production |
| Q36957096 | Association Between ABCB1 (MDR1) Gene Polymorphism and Unresponsiveness Combined Therapy in Chronic Hepatitis C virus |
| Q45733863 | Association between visceral obesity and hepatitis C infection stratified by gender: a cross-sectional study in Taiwan |
| Q35772369 | Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels |
| Q47112537 | Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy |
| Q39214596 | Association of lipid droplet and hepatitis C virus proteins: insights for virus replication |
| Q38244931 | Asunaprevir-containing regimens for the treatment of hepatitis C virus infection. |
| Q34069393 | Autophagy in HCV infection: keeping fat and inflammation at bay |
| Q35040770 | Bidirectional lipid droplet velocities are controlled by differential binding strengths of HCV core DII protein |
| Q36741121 | Bioenergetics of murine lungs infected with respiratory syncytial virus |
| Q43852099 | Biomarker discovery from the top down: Protein biomarkers for efficient virus transmission by insects (Homoptera: Aphididae) discovered by coupling genetics and 2-D DIGE. |
| Q47547562 | Calcitriol Inhibits HCV Infection via Blockade of Activation of PPAR and Interference with Endoplasmic Reticulum-Associated Degradation. |
| Q27469080 | Cell-death-inducing DFFA-like Effector B Contributes to the Assembly of Hepatitis C Virus (HCV) Particles and Interacts with HCV NS5A |
| Q38402247 | Cellular stress responses in hepatitis C virus infection: Mastering a two-edged sword |
| Q64240551 | Changes in serum LDL, PCSK9 and microRNA-122 in patients with chronic HCV infection receiving Daclatasvir/Asunaprevir |
| Q35626712 | Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture |
| Q37891171 | Cholesterol and chronic hepatitis C virus infection. |
| Q38833111 | Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance |
| Q52686867 | Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. |
| Q38868883 | Dengue Virus Uses a Non-Canonical Function of the Host GBF1-Arf-COPI System for Capsid Protein Accumulation on Lipid Droplets |
| Q47555446 | Dengue virus-induced ER stress is required for autophagy activation, viral replication, and pathogenesis both in vitro and in vivo |
| Q40074576 | Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients. |
| Q90417654 | Differentially expressed serum host proteins in hepatitis B and C viral infections |
| Q92061524 | Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges |
| Q34046758 | Distinct patterns of the lipid alterations between genotype 1 and 2 chronic hepatitis C patients after viral clearance |
| Q39708548 | Do viruses subvert cholesterol homeostasis to induce host cubic membranes? |
| Q64885161 | Dysregulated fatty acid metabolism in hepatocellular carcinoma. |
| Q41109284 | Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES. |
| Q48513490 | Effect of branched-chain amino acid supplementation on insulin resistance and quality of life in chronic hepatitis C patients |
| Q35609581 | Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus |
| Q40142985 | Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients. |
| Q35709709 | Emerging role of lipid droplets in host/pathogen interactions. |
| Q64106316 | Etifoxine, a TSPO Ligand, Worsens Hepatitis C-Related Insulin Resistance but Relieves Lipid Accumulation |
| Q42871650 | Expression profile of lipid metabolism‐associated genes in hepatitis C virus‐infected human liver |
| Q43035286 | Expression profiles of genes associated with viral entry in HCV-infected human liver |
| Q41234890 | FR171456 is a specific inhibitor of mammalian NSDHL and yeast Erg26p |
| Q35137045 | Farnesyl-diphosphate farnesyltransferase 1 regulates hepatitis C virus propagation |
| Q35048926 | Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism |
| Q37713887 | Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus |
| Q37747068 | GRIM-19 Restricts HCV Replication by Attenuating Intracellular Lipid Accumulation. |
| Q35945962 | Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray |
| Q38772047 | Genotype 3 Infection: The Last Stand of Hepatitis C Virus |
| Q43040102 | Genotype rs8099917 near the IL28B gene and amino acid substitution at position 70 in the core region of the hepatitis C virus are determinants of serum apolipoprotein B-100 concentration in chronic hepatitis C. |
| Q42978417 | HCV core-induced nonobese hepatic steatosis is associated with hypoadiponectinemia and is ameliorated by adiponectin administration |
| Q89640781 | HCV infection causes cirrhosis in human by step-wise regulation of host genes involved in cellular functioning and defense during fibrosis: Identification of bio-markers |
| Q39631188 | Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP). |
| Q45351555 | Hepatic triglyceride lipase plays an essential role in changing the lipid metabolism in genotype 1b hepatitis C virus replicon cells and hepatitis C patients |
| Q26738856 | Hepatitis C Viral Infection in Children: Updated Review |
| Q37097593 | Hepatitis C Virus Increases Free Fatty Acids Absorption and Promotes its Replication Via Down-Regulating GADD45α Expression. |
| Q37593216 | Hepatitis C Virus-Induced Rab32 Aggregation and Its Implications for Virion Assembly |
| Q37073281 | Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis. |
| Q37513094 | Hepatitis C eradication with sofosbuvir leads to significant metabolic changes |
| Q39576325 | Hepatitis C variability, patterns of resistance, and impact on therapy |
| Q38933599 | Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era. |
| Q30360538 | Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis. |
| Q39443793 | Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism |
| Q35641048 | Hepatitis C virus attenuates mitochondrial lipid β-oxidation by downregulating mitochondrial trifunctional-protein expression |
| Q39629001 | Hepatitis C virus expressing flag-tagged envelope protein 2 has unaltered infectivity and density, is specifically neutralized by flag antibodies and can be purified by affinity chromatography |
| Q36913366 | Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly |
| Q37643968 | Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation. |
| Q33674227 | Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence |
| Q31045004 | Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents |
| Q38698148 | Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis |
| Q36016417 | Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream target |
| Q37682496 | Immunologic, metabolic and genetic factors in hepatitis C virus infection |
| Q96685843 | Impact of chronic HCV treatment on quality of life of patients with metabolic disorders in context of immunological disturbances |
| Q37743001 | Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b. |
| Q36347839 | Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β. |
| Q24308039 | Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C virus secretion |
| Q42744862 | Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics |
| Q27023055 | Innate immune responses in hepatitis C virus infection |
| Q57084668 | Insights into dengue virus genome replication |
| Q34263370 | Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression |
| Q33893794 | Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle |
| Q37654443 | Interaction between hepatitis C virus and metabolic factors |
| Q37983638 | Interaction networks of hepatitis C virus NS4B: implications for antiviral therapy |
| Q36457831 | Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response. |
| Q36790471 | Interplay between Hepatitis C Virus and Redox Cell Signaling |
| Q35224602 | Japanese encephalitis virus nonstructural protein NS5 interacts with mitochondrial trifunctional protein and impairs fatty acid β-oxidation |
| Q34164235 | Lipid Droplets as Signaling Platforms Linking Metabolic and Cellular Functions |
| Q34028156 | Lipid droplets: size matters |
| Q28081216 | Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes |
| Q41292718 | Lipids: a key player in the battle between the host and microorganisms |
| Q38743914 | Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation |
| Q39340978 | Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication. |
| Q37370730 | MTP -493G/T gene polymorphism is associated with steatosis in hepatitis C-infected patients |
| Q60640976 | Metabolic Syndrome in Transplant Patients: An Academic or a Health Burden? |
| Q26773261 | Metabolic alterations and hepatitis C: From bench to bedside |
| Q28073134 | Metabolic complications in liver transplant recipients |
| Q36026554 | Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments |
| Q28083493 | Mitochondrial dynamics and viral infections: A close nexus |
| Q26740423 | Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma |
| Q27330093 | Multiple Infectious Agents and the Origins of Atherosclerotic Coronary Artery Disease |
| Q21245057 | Multiple functions of microsomal triglyceride transfer protein |
| Q24309143 | Nonstructural 5A protein of hepatitis C virus interacts with pyruvate carboxylase and modulates viral propagation |
| Q34578014 | Not just fat: the structure and function of the lipid droplet |
| Q33602824 | Novel permissive cell lines for complete propagation of hepatitis C virus |
| Q36489340 | Oxidative Stress Attenuates Lipid Synthesis and Increases Mitochondrial Fatty Acid Oxidation in Hepatoma Cells Infected with Hepatitis C Virus |
| Q37512558 | Perturbations of lipid metabolism indexed by lipidomic biomarkers |
| Q36395871 | Phosphoinositides in the hepatitis C virus life cycle. |
| Q58086440 | Phospholipid Remodeling in Physiology and Disease |
| Q34576190 | Potential treatment options and future research to increase hepatitis C virus treatment response rate |
| Q28543090 | Predictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3 |
| Q40503132 | Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection |
| Q92360212 | Profiling of plasma metabolomics in patients with hepatitis C-related liver cirrhosis and hepatocellular carcinoma |
| Q33637110 | Properties and Functions of the Dengue Virus Capsid Protein |
| Q34719596 | Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein |
| Q37428301 | Proteomic profiling of serum samples from chikungunya-infected patients provides insights into host response |
| Q90441154 | RNA Sequencing revealed differentially expressed genes functionally associated with immunity and tumor suppression during latent phase infection of a vv + MDV in chickens |
| Q37609538 | RNA helicase DDX3 maintains lipid homeostasis through upregulation of the microsomal triglyceride transfer protein by interacting with HNF4 and SHP. |
| Q35377680 | RNA virus replication depends on enrichment of phosphatidylethanolamine at replication sites in subcellular membranes |
| Q45323722 | Rapid Changes in Serum Lipid Profiles during Combination Therapy with Daclatasvir and Asunaprevir in Patients Infected with Hepatitis C Virus Genotype 1b. |
| Q40659169 | Release of Infectious Hepatitis C Virus from Huh7 Cells Occurs via a trans-Golgi Network-to-Endosome Pathway Independent of Very-Low-Density Lipoprotein Secretion |
| Q89450069 | Repurposing matrine for the treatment of hepatosteatosis and associated disorders in glucose homeostasis in mice |
| Q37141091 | Resistin reinforces interferon λ-3 to eliminate hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphisms. |
| Q30431638 | Role for ADP Ribosylation Factor 1 in the Regulation of Hepatitis C Virus Replication |
| Q37882865 | Role of lipids in virus replication |
| Q36201703 | Role of phosphatidylinositol 4-phosphate (PI4P) and its binding protein GOLPH3 in hepatitis C virus secretion. |
| Q34390521 | Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis |
| Q92452559 | Serine protease inhibitor AEBSF reduces dengue virus infection via decreased cholesterol synthesis |
| Q36051167 | Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users |
| Q42278798 | Serum apolipoprotein B-100 concentration predicts the virological response to pegylated interferon plus ribavirin combination therapy in patients infected with chronic hepatitis C virus genotype 1b. |
| Q84514392 | Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis |
| Q42275118 | Serum lipoprotein profiles and response to pegylated interferon plus ribavirin combination therapy in patients with chronic HCV genotype 1b infection |
| Q36891841 | Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area |
| Q37066551 | Silencing of Small Valosin-containing Protein-interacting Protein (SVIP) Reduces Very Low Density Lipoprotein (VLDL) Secretion from Rat Hepatocytes by Disrupting Its Endoplasmic Reticulum (ER)-to-Golgi Trafficking |
| Q36062956 | Simultaneous quantification of salivary 3-hydroxybutyrate, 3-hydroxyisobutyrate, 3-hydroxy-3-methylbutyrate, and 2-hydroxybutyrate as possible markers of amino acid and fatty acid catabolic pathways by LC-ESI-MS/MS. |
| Q37708986 | Small heterodimer partner 1 directly interacts with NS5A viral protein and has a key role in HCV related liver cell transformation. |
| Q99557052 | Sphingomyelin Is Essential for the Structure and Function of the Double-Membrane Vesicles in the Viral RNA Replication Factories |
| Q28084730 | Stealing the Keys to the Kitchen: Viral Manipulation of the Host Cell Metabolic Network |
| Q91710585 | Subversion of cellular autophagy during virus infection: Insights from hepatitis B and hepatitis C viruses |
| Q27014838 | Targeting autophagy for the treatment of liver diseases |
| Q37400658 | The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling |
| Q34190545 | The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus |
| Q33851915 | The Evolving Interplay among Abundant Adipokines in Patients with Hepatitis C during Viral Clearance |
| Q36573945 | The Hepatitis C Virus-induced NLRP3 Inflammasome Activates the Sterol Regulatory Element-binding Protein (SREBP) and Regulates Lipid Metabolism |
| Q38969477 | The Intracellular Cholesterol Landscape: Dynamic Integrator of the Immune Response |
| Q38760883 | The LXR ligand GW3965 inhibits Newcastle disease virus infection by affecting cholesterol homeostasis |
| Q88153292 | The Use of Statins in Patients With Chronic Liver Disease and Cirrhosis |
| Q58088572 | The aryl hydrocarbon receptor-cytochrome P450 1A1 pathway controls lipid accumulation and enhances the permissiveness for hepatitis C virus assembly |
| Q35927970 | The high comorbidity burden of the hepatitis C virus infected population in the United States |
| Q42211503 | The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: a meta-analysis. |
| Q40414261 | The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis. |
| Q34417092 | The virus as metabolic engineer |
| Q34289586 | Three-dimensional visualization of forming Hepatitis C virus-like particles by electron-tomography |
| Q42256831 | Tombusvirus replication depends on Sec39p endoplasmic reticulum-associated transport protein |
| Q42143878 | Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro |
| Q38741769 | Treatment of dyslipidemia with statins by primary care providers in Veterans with and without chronic Hepatitis C. |
| Q38971183 | Type I interferon rapidly restricts infectious hepatitis C virus particle genesis. |
| Q33627666 | Understanding PRRSV infection in porcine lung based on genome-wide transcriptome response identified by deep sequencing |
| Q37865821 | Unique ties between hepatitis C virus replication and intracellular lipids. |
| Q35125004 | Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection |
| Q41687237 | Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection |
| Q90053464 | Very-long-chain fatty acid metabolic capacity of 17-beta-hydroxysteroid dehydrogenase type 12 (HSD17B12) promotes replication of hepatitis C virus and related flaviviruses |
| Q35582251 | Viral activation of cellular metabolism |
| Q37281965 | Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma. |
Search more.